Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

17

Number of overlapping holdings

19.1%

% of WDNA's 91 holdings also in BBH

68.0%

% of BBH's 27 holdings also in WDNA

Overlap by Weight
Sector Drift (WDNA minus BBH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in WDNA
Weight
in BBH
Overlap
NATERA INC 1.9% 2.3% 1.9%
VERTEX PHARMACEUTICALS INC 1.3% 9.7% 1.3%
REPLIGEN CORP 1.2% 1.7% 1.2%
REGENERON PHARMACEUTICALS 1.2% 7.9% 1.2%
SAREPTA THERAPEUTICS INC 1.1% 2.4% 1.1%

Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to BBH
IOVANCE BIOTHERAPEUTICS INC 3.9%
TWIST BIOSCIENCE CORP. 3.4%
FATE THERAPEUTICS INC 3.1%
NOVOZYMES A/S-B SHARES 2.4%
BLUEPRINT MEDICINES CORP. 2.2%
BRIDGEBIO PHARMA, INC. 2.0%
ELI LILLY & CO 1.9%
ALCOBRA LTD 1.7%
VERICEL CORPORATION 1.7%
AGIOS PHARMACEUTICALS INC 1.6%
WDNA Underweight Relative to BBH
AMGEN INC -14.2%
VERTEX PHARMACEUTICALS INC -8.4%
GILEAD SCIENCES INC -7.1%
REGENERON PHARMACEUTICALS -6.7%
MODERNA, INC. -4.9%
IQVIA HOLDINGS INC -4.9%
ARGENX SE ADR -4.4%
ICON PLC -4.2%
BIOGEN IDEC INC -3.5%
ILLUMINA INC -3.5%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY